I started looking into PIQ investment when the deal for PromarkerD was announced with DXB to be used in their trials, where I’m also invested. PromarkerD was a big WOW factor for me after research into CKD & DKD & the cost to healthcare globally for treating kidney disease. Being a predictive test, the savings for Govts are huge & to be able to change the path of declining kidney function for patients before this occurs clinically, is a massive plus.
I also looked at the huge potential in this company when investing & after a few positive announcements recently, it’s only a matter of time. Not one to count chickens before they hatch, but would be no surprise to me that USA Medicare doesn’t take this on as a screening test with the many billions they spend on kidney disease each year & now preventative programmes (articles posted here previously).
I think when we see revenue it will snowball & seeing more regions come on board, this will happen quickly. GLTAH especially the longs. Was lucky to get in when I did, it seems.
PIQ Price at posting:
29.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)